NFC
AZN icon

Northstar Financial Companies’s AstraZeneca AZN Stock Holding History

Northstar Financial Companies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Sell
1,652
-267
-14% -$50.2K 0.21% 89
2026
Q1 		$378K Sell
1,919
-2
-0.1% -$386 0.3% 71
2025
Q4 		$353K Sell
1,921
-197
-9% -$34.6K 0.28% 79
2025
Q3 		$325K Buy
2,118
+8
+0.4% +$1.21K 0.3% 73
2025
Q2 		$295K Sell
2,110
-56
-3% -$7.85K 0.31% 77
2025
Q1 		$318K Buy
2,166
+53
+3% +$7.67K 0.35% 71
2024
Q4 		$277K Buy
+2,113
New +$296K 0.26% 85

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Northstar Financial Companies's AZN Position: Q2 2026 in Review

Northstar Financial Companies reduced its AstraZeneca (AZN) stake by 14% in Q2 2026, selling an estimated $50.2K and leaving 1,652 shares worth $313K. The position accounts for 0.21% of the portfolio, ranked #89.

Northstar Financial Companies first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $378K in Q1 2026. 878 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Northstar Financial Companies held 1,652 shares of AstraZeneca worth $313K as of Q2 2026.
  • Northstar Financial Companies sold 267 AstraZeneca shares in Q2 2026, an estimated $50.2K.
  • AstraZeneca made up 0.21% of Northstar Financial Companies's portfolio in Q2 2026, its #89 holding.
  • Northstar Financial Companies first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
  • Northstar Financial Companies's AstraZeneca position peaked at $378K in Q1 2026.
  • 878 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Northstar Financial Companies's 13F filing for Q2 2026, filed 6 Aug 2026.